Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Anti-GPC3-scFvGC33-CAR autologous T lymphocytes |
| Trade Name | |
| Synonyms | GAP T cells|GLYCAR T cells |
| Drug Descriptions |
Anti-GPC3-scFvGC33-CAR autologous T lymphocytes are autologous T-cells that have been engineered to express a chimeric antigen receptor (CAR) based on an antibody (GC33) that targets GPC3, which may induce lysis of GPC3-expressing tumor cells (NCI Drug Dictionary). |
| DrugClasses | GPC3 Immune Cell Therapy 8 |
| CAS Registry Number | NA |
| NCIT ID | C132989 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Anti-GPC3-scFvGC33-CAR autologous T lymphocytes | Anti-GPC3-scFvGC33-CAR autologous T lymphocytes | 0 | 2 |